57 studies were found. Here are studies 1 to 50.

1.		Recruiting	Chemotherapy in Treating Children With Liver Cancer Conditions: childhood hepatoblastoma; childhood hepatocellular carcinoma; childhood liver cancer
2.		Recruiting	Study of Botanical PHY906 Plus Capecitabine for Advanced Unresectable Hepatocellular Carcinoma Conditions: Hepatocellular Carcinoma; Liver Cancer
3.		Recruiting	Study of DENSPM in Patients with Liver Cancer who are Not Eligible for Surgical Cure Condition: Carcinoma, Hepatocellular
4.		Recruiting	Vaccine Therapy in Treating Patients With Liver Cancer Conditions: localized resectable adult primary liver cancer; localized unresectable adult primary liver cancer; advanced adult primary liver cancer; ...
5.		Recruiting	A Study to Estimate Safety and Efficacy of Bay 43-9006 in the Treatment of Hepatocellular Carcinoma Condition: Carcinoma, Hepatocellular
6.		Recruiting	Vaccine Therapy in Treating Patients With Stage II, Stage III, or Stage IVA Liver Cancer Conditions: adult primary hepatocellular carcinoma; advanced adult primary liver cancer; localized resectable adult primary liver cancer; ...
7.		Recruiting	Doxorubicin and Bortezomib in Treating Patients With Liver Cancer Conditions: adult primary hepatocellular carcinoma; advanced adult primary liver cancer; recurrent adult primary liver cancer; ...
8.		Recruiting	Bortezomib in Treating Patients With Hepatocellular Carcinoma (Liver Cancer) Conditions: adult primary hepatocellular carcinoma; advanced adult primary liver cancer; localized unresectable adult primary liver cancer; ...
9.		Recruiting	TAC-101 in Treating Patients With Advanced Hepatocellular Carcinoma (Liver Cancer) Conditions: advanced adult primary liver cancer; recurrent adult primary liver cancer; adult primary hepatocellular carcinoma; ...
10.		Recruiting	Epirubicin and Thalidomide in Treating Patients With Liver Cancer Conditions: adult primary hepatocellular carcinoma; advanced adult primary liver cancer; localized unresectable adult primary liver cancer; ...
11.		Recruiting	Oxaliplatin in Treating Patients With Liver Cancer Conditions: advanced adult primary liver cancer; localized unresectable adult primary liver cancer; recurrent adult primary liver cancer; ...
12.		Recruiting	Erlotinib in Treating Patients With Unresectable Liver Cancer and Liver Dysfunction Conditions: recurrent adult primary liver cancer; localized unresectable adult primary liver cancer; advanced adult primary liver cancer; ...
13.		Recruiting	Oblimersen and Doxorubicin in Treating Patients With Advanced Hepatocellular Carcinoma (Liver Cancer) Conditions: adult primary hepatocellular carcinoma; advanced adult primary liver cancer; localized unresectable adult primary liver cancer; ...
14.		Recruiting	Nolatrexed Dihydrochloride Compared With Doxorubicin in Treating Patients With Recurrent or Unresectable Liver Cancer Conditions: localized unresectable adult primary liver cancer; advanced adult primary liver cancer; recurrent adult primary liver cancer; ...
15.		Recruiting	Chemoembolization in Treating Patients With Primary Liver Cancer or Metastases to the Liver Conditions: localized unresectable adult primary liver cancer; advanced adult primary liver cancer; recurrent adult primary liver cancer; ...
16.		Recruiting	Heat Activated Liposomal Doxorubicin and Radiofrequency Ablation in Treating Patients With Primary or Metastatic Liver Tumors Conditions: advanced adult primary liver cancer; liver metastases; localized unresectable adult primary liver cancer; recurrent adult primary liver cancer
17.		Recruiting	Irinotecan and Flavopiridol in Treating Patients With Advanced Liver Cancer Conditions: adult primary hepatocellular carcinoma; advanced adult primary liver cancer; recurrent adult primary liver cancer
18.		Recruiting	Positron Emission Tomography Using Carbon-11 Acetate and Fludeoxyglucose F 18 in Detecting Hepatocellular Carcinoma (Liver Cancer) in Patients With Known or Suspected Liver Cancer Conditions: adult primary hepatocellular carcinoma; recurrent adult primary liver cancer; localized resectable adult primary liver cancer
19.		Recruiting	Bevacizumab in Treating Patients With Unresectable Nonmetastatic Liver Cancer Conditions: adult primary hepatocellular carcinoma; recurrent adult primary liver cancer; localized unresectable adult primary liver cancer
20.		Recruiting	Chemoembolization and Bevacizumab in Treating Patients With Liver Cancer That Cannot Be Removed With Surgery Conditions: localized unresectable adult primary liver cancer; recurrent adult primary liver cancer; adult primary hepatocellular carcinoma
21.		Recruiting	Erlotinib in Treating Patients With Liver Cancer That Cannot be Surgically Removed Conditions: adult primary hepatocellular carcinoma; advanced adult primary liver cancer; localized unresectable adult primary liver cancer
22.		Recruiting	Megestrol in Treating Patients With Liver Cancer That Cannot Be Removed By Surgery Conditions: localized unresectable adult primary liver cancer; advanced adult primary liver cancer; adult primary hepatocellular carcinoma
23.		Recruiting	Hepatic Arterial Infusion Plus Internal Radiation Therapy in Treating Patients With Liver Cancer That Cannot Be Removed By Surgery Conditions: localized unresectable adult primary liver cancer; recurrent adult primary liver cancer; adult primary hepatocellular carcinoma
24.		Recruiting	Thalidomide and Chemoembolization With Doxorubicin in Treating Patients With Liver Cancer That Cannot be Removed by Surgery Conditions: localized unresectable adult primary liver cancer; advanced adult primary liver cancer; adult primary hepatocellular carcinoma
25.		Recruiting	A Trial of Thymalfasin in Adult Patients with Hepatocellular Carcinoma Condition: Carcinoma, Hepatocellular
26.		Recruiting	Safety and Efficacy Study of a Caspase Inhibitor in Patients Undergoing Liver Transplantation Conditions: Liver Transplantation; Hepatitis; Cholestasis; Carcinoma, Hepatocellular
27.		Recruiting	Testing of ADI-PEG in Hepatocellular Carcinoma Condition: Carcinoma, Hepatocellular
28.		Recruiting	BMS-247550 in Treating Patients With Liver or Gallbladder Cancer Conditions: adult primary liver cancer; extrahepatic bile duct cancer; Gallbladder Cancer
29.		Recruiting	Bortezomib in Treating Patients With Advanced Cancer and Liver Dysfunction Conditions: adult non-Hodgkin's lymphoma; adult primary liver cancer; adult solid tumor
30.		Recruiting	Bortezomib as First-Line Systemic Therapy in Treating Patients With Unresectable Locally Advanced or Metastatic Adenocarcinoma of the Bile Duct or Gallbladder Conditions: adult primary liver cancer; extrahepatic bile duct cancer; Gallbladder Cancer
31.		Recruiting	Adjuvant Palliative Capecitabine and Gemcitabine in Treating Patients With Locally Advanced or Metastatic Biliary Tract Cancer Conditions: adult primary liver cancer; extrahepatic bile duct cancer; Gallbladder Cancer; Pain
32.		Recruiting	Rebeccamycin Analogue in Treating Patients With Advanced Liver and/or Biliary Cancer Conditions: adult primary liver cancer; cholangiocarcinoma of the extrahepatic bile duct; cholangiocarcinoma of the gallbladder; ...
33.		Recruiting	Doxorubicin With or Without Chemoembolization in Treating Patients With Advanced Unresectable Hepatocellular Carcinoma (Liver Cancer) Conditions: advanced adult primary liver cancer; adult primary hepatocellular carcinoma
34.		Recruiting	Radioactive Iodine in Treating Patients Who Have Undergone Surgery for Liver Cancer Conditions: localized resectable adult primary liver cancer; adult primary hepatocellular carcinoma
35.		Recruiting	Combination Chemotherapy With or Without Amifostine in Treating Young Patients With Liver Cancer Conditions: stage I childhood liver cancer; recurrent childhood liver cancer; childhood hepatoblastoma
36.		Recruiting	Safety and Tolerability of I.V. Infusion of MB07133 in Patients with Unresectable Hepatocellular Carcinoma Condition: Hepatocellular Carcinoma
37.		Recruiting	Prevention of Recurrent Hepatitis B after Liver Transplantation Conditions: Hepatitis B; Cirrhosis; Acute Liver Failure; Hepatocellular Carcinoma
38.		Recruiting	Liver Perfusion for Patients with Inoperable Liver Cancer Condition: Liver Cancer
39.		Recruiting	Combination Chemotherapy and Tamoxifen in Treating Patients With Solid Tumors Condition: Cancer
40.		Recruiting	EF5 and Motexafin Lutetium in Detecting Tumor Cells in Patients With Abdominal Cancer Conditions: Endocrine Cancer; female reproductive cancer; Gastrointestinal Cancer; musculoskeletal cancer; unclassified and other cancer
41.		Recruiting	Erlotinib in Treating Patients With Solid Tumors and Liver or Kidney Dysfunction Condition: Cancer
42.		Recruiting	Vaccine Therapy in Treating Patients With Advanced or Metastatic Cancer Conditions: Breast Cancer; Endocrine Cancer; female reproductive cancer; Gastrointestinal Cancer; Head and Neck Cancer
43.		Recruiting	Arsenic Trioxide in Treating Patients With Advanced Neuroblastoma or Other Childhood Solid Tumors Condition: childhood cancer
44.		Recruiting	Capecitabine Combined with Cisplatin in Treating Patients With Locally Advanced or Metastatic Solid Tumors Conditions: Breast Cancer; Gastrointestinal Cancer; Head and Neck Cancer; thorax and respiratory cancer; unclassified and other cancer
45.		Recruiting	Chronic Thalidomide Administration in Patients Undergoing Chemoembolization for Unresectable Hepatocellular Cancer Condition: Liver Cancer
46.		Not yet recruiting	Oxaliplatin in Treating Young Patients With Recurrent Solid Tumors That Have Not Responded to Previous Treatment Condition: Cancer
47.		Recruiting	Intravenous VEGF Trap in Treating Patients With Relapsed or Refractory Advanced Solid Tumors or Non-Hodgkin's Lymphoma Condition: Cancer
48.		Recruiting	Intravenous VEGF Trap in Treating Patients With Relapsed or Refractory Advanced Solid Tumors or Non-Hodgkin's Lymphoma Condition: Cancer
49.		Recruiting	Thalidomide and Docetaxel in Treating Patients With Advanced Cancer Condition: Cancer
50.		Recruiting	ABT-751 in Treating Young Patients With Refractory Solid Tumors Condition: childhood cancer